Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Akero Therapeutics Inc shares valued at $251,274 were sold by Yale Catriona on Nov 15 ’24. At $27.73 per share, Yale Catriona sold 9,061 shares. The insider’s holdings dropped to 74,158 shares worth approximately $2.27 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Yale Catriona sold 10,000 shares, netting a total of over 351,890 in proceeds. Following the sale of shares at $35.19 each, the insider now holds 74,158 shares.
Before that, CATRIONA YALE had added 10,000 shares to its account. In a trade valued at $327,400, the Officer bought Akero Therapeutics Inc shares for $32.74 each.
As published in their initiating research note from Citigroup on November 18, 2024, Akero Therapeutics Inc [AKRO] has been a Buy and the price target has been revised to $65. As of September 19, 2023, Cantor Fitzgerald has initiated its “an Overweight” rating for AKRO. Earlier on August 28, 2023, UBS initiated its rating. Their recommendation was “a Buy” for AKRO stock.
Analyzing AKRO Stock Performance
During the last five days, there has been a drop of approximately -1.08%. Over the course of the year, Akero Therapeutics Inc shares have jumped approximately 31.20%. Shares of the company reached a 52-week high of $37.00 on 03/04/24 and a 52-week low of $15.32 on 02/06/24. A 50-day SMA is recorded $29.73, while a 200-day SMA reached $25.28. Nevertheless, trading volume fell to 0.44 million shares from 0.8 million shares the previous day.
Support And Resistance Levels for Akero Therapeutics Inc (AKRO)
According to the 24-hour chart, there is a support level at 29.81, which, if violated, would cause prices to drop to 28.98. In the upper region, resistance lies at 31.53. The next price resistance is at 32.43. RSI (Relative Strength Index) is 49.43 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.53, which suggests the price will decrease in the coming days. Percent R is at 59.38%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
